Efficacy and safety of odevixibat in patients with Alagille syndrome (ASSERT): a phase 3, double-blind, randomised, placebo-controlled trial
Nadia Ovchinsky,Madeleine Aumar,Alastair Baker,Ulrich Baumann,Philip Bufler,Mara Cananzi,Piotr Czubkowski,Özlem Durmaz,Ryan Fischer,Giuseppe Indolfi,Wikrom W Karnsakul,Florence Lacaille, Way S Lee,Giuseppe Maggiore,Philip Rosenthal,Mathias Ruiz,Etienne Sokal,Ekkehard Sturm, Wendy van der Woerd,Henkjan J Verkade,Andrew Wehrman,Christine Clemson,Qifeng Yu,Quanhong Ni, Jessica Ruvido, Susan Manganaro,Jan P Mattsson The Lancet Gastroenterology & Hepatology（2024）
AI 理解论文
溯源树
样例
